Safety Study and Compositional Analysis of the Svarnvir-IV Tablet With Special Reference to Its Therapeutic Utility in SARS-CoV-2.
Reddy KR, Kumari P, Vinay K, Singh J, Chauhan BS, Kumar P, Srikrishna S, Kumar D, Mishra M, Singaravel M, Prasad NK, Anuraag NS, Sahni C, Sharma S.
Reddy KR, et al. Among authors: kumar d.
Cureus. 2024 Dec 10;16(12):e75438. doi: 10.7759/cureus.75438. eCollection 2024 Dec.
Cureus. 2024.
PMID: 39791040
Free PMC article.